![David McIntyre](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David McIntyre
Directeur Financier/CFO chez
INHIBIKASE THERAPEUTICS, INC.
Fortune : 225 593 $ au 30/06/2026
Profil
David John McIntyre is currently Director at Vytronus, Inc. since 2014; Director at Tendyne Holdings, Inc.; Independent Non-Executive Director at Starpharma Holdings Ltd. since 2020; Treasurer, Chief Financial Officer, Director & EVP at Braeburn, Inc. since 2016; Director at Petalion Therapeutics Ltd.; Trustee at Fisher House Foundation, Inc. since 2010; Member of The Law Society of New South Wales; and Chief Financial Officer at Inhibikase Therapeutics, Inc. starting 2025.
Former positions include Director at Avedro, Inc., Gala Therapeutics, Inc., Tusker Medical, Inc., and ROX Medical, Inc.; Independent Non-Executive Director at Redflex Holdings Pty Ltd.; Non-Executive Director at ROX Medical, Inc.; CFO, Secretary & Chief Business Officer at Heartware Pty Ltd.; Senior Attorney at Baker & McKenzie LLP (Illinois) and KPMG Legal in 2003; Chief Financial Officer at AVITA Medical Pty Ltd. from 2019 to 2020; Chief Operating & Financial Officer & Executive VP at HeartWare International LLC in 2011; Chief Financial Officer at Tessa Therapeutics Ltd from 2020 to 2021; Chief Financial Officer at Anthos Therapeutics, Inc. from 2021 to 2024; Chief Financial Officer at AVITA Medical, Inc.; and Partner at Apple Tree Venture Management LLC from 2012 to 2020.
Education includes undergraduate studies at The University of Sydney, graduate studies at the University of Technology Sydney, and an MBA from The Fuqua School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/06/2025 | 422 126 ( 0,1 % ) | 204 714 $ | 30/06/2026 | |
| 15/04/2026 | 10 285 ( 0,01 % ) | 20 879 $ | 30/06/2026 |
Postes actifs de David McIntyre
| Sociétés | Poste | Début |
|---|---|---|
| BRAEBURN INC. | Directeur Financier/CFO | 01/10/2016 |
| STARPHARMA HOLDINGS LIMITED | Directeur/Membre du Conseil | 01/03/2020 |
| INHIBIKASE THERAPEUTICS, INC. | Directeur Financier/CFO | 14/04/2025 |
Tendyne Holdings, Inc.
 Tendyne Holdings, Inc. Medical SpecialtiesHealth Technology Develops technologies and therapies for the treatment of mitral regurgitation | Directeur/Membre du Conseil | - |
Vytronus, Inc.
 Vytronus, Inc. Medical SpecialtiesHealth Technology Manufactures imaging and therapeutic medical devices | Directeur/Membre du Conseil | 30/10/2014 |
Fisher House Foundation, Inc.
 Fisher House Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Provides humanitarian and military services | Directeur/Membre du Conseil | - |
The Law Society of New South Wales | Corporate Officer/Principal | - |
Anciens postes connus de David McIntyre
| Sociétés | Poste | Fin |
|---|---|---|
Anthos Therapeutics, Inc.
 Anthos Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutic options for the treatment of cardiovascular metabolic diseases | Directeur Financier/CFO | 01/10/2024 |
Tessa Therapeutics Ltd
 Tessa Therapeutics Ltd BiotechnologyHealth Technology Engages in the development and commercialization of cancer immunotherapies | Directeur Financier/CFO | 01/10/2021 |
| ░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Formation de David McIntyre
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
56
Relations au 1er degré
24
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 24 |
|---|---|
ROX Medical, Inc.
 ROX Medical, Inc. Medical SpecialtiesHealth Technology Manufactures medical ultrasonic scanning devices | Health Technology |
Heartware Pty Ltd.
 Heartware Pty Ltd. Medical SpecialtiesHealth Technology Develops & manufactures implantable circulatory assist devices | Health Technology |
Avedro, Inc.
 Avedro, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ophthalmic pharmaceuticals & medical devices | Health Technology |
Vytronus, Inc.
Vytronus, Inc. Medical SpecialtiesHealth Technology Manufactures imaging and therapeutic medical devices | Health Technology |
Tendyne Holdings, Inc.
Tendyne Holdings, Inc. Medical SpecialtiesHealth Technology Develops technologies and therapies for the treatment of mitral regurgitation | Health Technology |
Starpharma Holdings Ltd.
 Starpharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development of dendrimer products for pharmaceutical, life science & other applications | Health Technology |
Redflex Holdings Pty Ltd.
 Redflex Holdings Pty Ltd. Electronic Equipment/InstrumentsElectronic Technology Develops and manufactures automated traffic enforcement products | Electronic Technology |
Baker & McKenzie LLP (Illinois)
 Baker & McKenzie LLP (Illinois) Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
KPMG Legal
 KPMG Legal Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
The University of Sydney
 The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Technology Sydney
 University of Technology Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Apple Tree Venture Management Llc//vc
 Apple Tree Venture Management Llc//vc Investment ManagersFinance Apple Tree Partners invests in companies located in the United States. The firm focuses on the life sciences sector. It provides financing for seed, early and later stage capital requirements. | Finance |
Fisher House Foundation, Inc.
Fisher House Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Provides humanitarian and military services | Commercial Services |
The Law Society of New South Wales | |
AVITA Medical Pty Ltd.
 AVITA Medical Pty Ltd. BiotechnologyHealth Technology Develops and distributes products in regenerative and respiratory medicine | Health Technology |
HeartWare International LLC
 HeartWare International LLC Medical SpecialtiesHealth Technology Develops and manufactures implantable heart pumps | Health Technology |
Inhibikase Therapeutics, Inc.
 Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
The Fuqua School of Business
 The Fuqua School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tessa Therapeutics Ltd
Tessa Therapeutics Ltd BiotechnologyHealth Technology Engages in the development and commercialization of cancer immunotherapies | Health Technology |
Braeburn, Inc.
 Braeburn, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and manufactures pharmaceutical products for opioid use disorder | Commercial Services |
Gala Therapeutics, Inc.
 Gala Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops medical devices for pulmonary diseases | Health Technology |
Tusker Medical, Inc.
 Tusker Medical, Inc. Medical SpecialtiesHealth Technology Develops medical devices for ear, nose and throat treatments | Health Technology |
Anthos Therapeutics, Inc.
Anthos Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutic options for the treatment of cardiovascular metabolic diseases | Health Technology |
AVITA Medical, Inc.
 AVITA Medical, Inc. Medical SpecialtiesHealth Technology Develops and commercializes medical devices for regenerative medicine | Health Technology |
Choisissez Zonebourse 
